BSE filing, NSE: LAURLOR. Summary written from the filing by ALFA Finder's alert engine.
Kimia Biosciences Ltd: key numbers
- Share price
- ₹30.70
- Market cap
- ₹145.2 Cr
- Revenue (annual)
- ₹114.9 Cr
- Net profit (annual)
- ₹7.43 Cr
- P/E (TTM)
- 20.2×Sector 41.3×
- Promoter holding
- 74.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kimia Biosciences Ltd
All →Kimia Biosciences Other Announcement
Kimia Biosciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Kimia Biosciences Management Change
Kimia Biosciences Limited announced the re-appointment of Mr. Sameer Goel as Executive Director and changes in designation for three other directors on the board.
Kimia Biosciences Annual General Meeting
Kimia Biosciences Ltd filed the proceedings of its 33rd Annual General Meeting held on September 28, 2026, where shareholders considered various ordinary and special resolutions.
Kimia Biosciences Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended March 31, 2026.
Kimia Biosciences Annual General Meeting
Kimia Biosciences Limited has submitted its notice for the 33rd Annual General Meeting scheduled for September 28, 2026, along with the Annual Report for FY 2025-26.
Kimia Biosciences Board Meeting Outcome
Kimia Biosciences' board meeting outcome includes director appointments, approval of the 33rd AGM notice, and increased borrowing/investment limits. The board also adopted the annual report.
Other board meeting date announcements
All →Lime Chemicals Board Meeting Date
Lime Chemicals Ltd has scheduled a board meeting on November 14, 2026. The board will consider and approve unaudited financial results for the quarter ended September 30, 2026.
Punjab Communications Board Meeting Date
Punjab Communications will hold a board meeting on 13 November 2026 to consider unaudited standalone results for the half year ended September 2026. Trading window is closed from 1 October to 15 November 2026.
Amforge Industries Board Meeting Date
Amforge Industries Limited will hold a board meeting on November 13, 2026. The board will consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Midwest Board Meeting Date
Midwest Limited has scheduled a board meeting for November 10, 2026. The board will consider and approve the company's standalone and consolidated financial results.
Elango Industries Board Meeting Date
Elango Industries scheduled a board meeting on November 13, 2026, to approve unaudited financial results. This meeting covers the quarter and half-year ended September 30, 2026.
Baweja Studios Board Meeting Date
Baweja Studios Limited will hold a board meeting on November 14, 2026. The board will consider and approve half-yearly unaudited financial results.